EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

PCSK9 promotes atherosclerosis progression through the FOXO3a autophagy signaling pathway

Yuanjia Shi, Jing Zhang, Lina Dai, Jie Chen, Shijia Geng, Yan Niu, Chongyang Dong, Chenlei Li, Rujin Liu, Ningxia Zhao, Xiaomeng Wang, Zhanfeng Gao und 2 weitere

Frontiers in Cardiovascular Medicine · 15.06.2026 · 13

DOI: 10.3389/fcvm.2026.1836294 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 15.06.2026. Verfasst von Yuanjia Shi und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Basic Medicine, School of Basic Medical Sciences, Inner Mongolia Medical University, Hohhot, China. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives The proprotein convertase subtilisin/kexin type 9 (PCSK9) has an impact on atherosclerosis by modulating the autophagy pathway; however, its precise mechanisms underlying autophagy require additional investigation. Methodology and results ApoE−/− male mice were fed high-fat diets, different doses of COS (Chitosan oligosaccharide) or JY2 were given by gavage, and RAPA or CQ was injected intraperitoneally. The immunofluorescence intensities of PCSK9, FOXO3a and LC3, collagen fibers and calcium salt deposition in aortic sinus tissues were measured. In vitro , macrophages were pretreated with oe/siPCSK9, COS, RAPA, CQ or JY2 combined with ox-LDL, and autophagy-related protein levels, autophagic flux and autophagy-related genes were detected. COS significantly reduced PCSK9 expression in Raw264.7 cells and autophagy-related protein expression, slowing the progression of atherosclerotic plaques, as shown by reduced plaque area, lipid deposition, and calcium salt deposition and increased collagen fibers. In macrophages derived from atherosclerotic plaques, the concentrations of PCSK9 and FOXO3a were markedly elevated in the RAPA group compared to the ND group. In vitro studies revealed that PCSK9 enhances the expression of Beclin1, P62, LC3, and FOXO3a, while also augmenting autophagic flux, thereby promoting ox-LDL-induced autophagic injury in macrophages, whereas COS inhibited the formation of PCSK9, thereby inhibiting autophagic injury. In addition, the FOXO3a inhibitor JY2 significantly inhibited autophagy but did not significantly affect PCSK9. In addition, oe/siPCSK9 affected the extent and flow of autophagy in macrophages. COS and CQ also limit PCSK9 in ApoE−/− mouse atherosclerosis progression and in macrophages subjected to autophagy. Conclusions and significance PCSK9 promotes macrophage autophagy injury and facilitates atherosclerosis progression through activation of the FOXO3a autophagy pathway, whereas COS reduces PCSK9 injury to macrophages and atherosclerosis. These findings provide a theoretical basis and experimental foundation for the future development of PCSK9 inhibitors as a new strategy for the treatment of As.

Schlagwörter

Stichwörter der Autor:innen

COSFOXO3aPCSK9atherosclerosisautophagy

Autor:innen und Institutionen

  • Department of Basic Medicine, School of Basic Medical Sciences, Inner Mongolia Medical University, Hohhot, China.
  • College of Basic Medicine, Inner Mongolia Medical University, Hohhot, China.
  • Medical Experiments Center, Inner Mongolia Medical University, Hohhot, China.
  • College of Traditional Chinese Medicine, Inner Mongolia Medical University, Hohhot, China.
  • Department of Cardiology, The Affiliated Hospital, Inner Mongolia Medical University, Hohhot, China.

Zitieren

APA

Shi, Y., Zhang, J., Dai, L., Chen, J., Geng, S., Niu, Y., Dong, C., Li, C., Liu, R., Zhao, N., Wang, X., Gao, Z., Yang, X., & Gao, S. (2026). PCSK9 promotes atherosclerosis progression through the FOXO3a autophagy signaling pathway. Frontiers in Cardiovascular Medicine, 13. https://doi.org/10.3389/fcvm.2026.1836294

Vancouver

Shi Y, Zhang J, Dai L, Chen J, Geng S, Niu Y, et al. PCSK9 promotes atherosclerosis progression through the FOXO3a autophagy signaling pathway. Frontiers in Cardiovascular Medicine. 2026;13. doi:10.3389/fcvm.2026.1836294

BibTeX
@article{Shi2026,
  author = {Shi, Yuanjia and Zhang, Jing and Dai, Lina and Chen, Jie and Geng, Shijia and Niu, Yan and Dong, Chongyang and Li, Chenlei and Liu, Rujin and Zhao, Ningxia and Wang, Xiaomeng and Gao, Zhanfeng and Yang, Xi and Gao, Shang},
  title = {PCSK9 promotes atherosclerosis progression through the FOXO3a autophagy signaling pathway},
  journal = {Frontiers in Cardiovascular Medicine},
  year = {2026},
  volume = {13},
  doi = {10.3389/fcvm.2026.1836294}
}
Kostenlos starten →